Differential modulation of TLR3-and TLR4-mediated dendritic cell maturation and function by progesterone

Journal of Immunology

Volumn 185, Issue 8, 2010, Pages 4525-4534

  Jones, Leigh A ^a   Kreem, Shrook ^a   Shweash, Muhannad ^a   Paul, Andrew ^a   Alexander, James ^a   Roberts, Craig W ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 12; INTERLEUKIN 6; NORGESTREL; PROGESTERONE; PROGESTERONE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; CYTOKINE; TLR3 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; INTERFERON PRODUCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RECEPTOR SENSITIVITY; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALE; MICE; MICE, INBRED BALB C; PROGESTERONE; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4;

EID: 78049489352     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901155     Document Type: Article

References (57)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
2. Belz, G., A. Mount, and F. Masson. 2009. Dendritic cells in viral infections. Handb. Exp. Pharmacol. 188:51-77.
3. Sher, A., E. Pearce, and P. Kaye. 2003. Shaping the immune response to parasites: role of dendritic cells. Curr. Opin. Immunol. 15:421-429.
4. Ni, K., and H. C. O'Neill. 1997. The role of dendritic cells in T cell activation. Immunol. Cell Biol. 75:223-230.
5. Schuurhuis, D. H., N. Fu, F. Ossendorp, and C. J. Melief. 2006. Ins and outs of dendritic cells. Int. Arch. Allergy Immunol. 140:53-72.
6. Piccinni, M.-P., E. Maggi, and S. Romagnani. 2000. Role of hormone-controlled T-cell cytokines in the maintenance of pregnancy. Biochem. Soc. Trans. 28:212-215.
7. Raghupathy, R., and J. Kalinka. 2008. Cytokine imbalance in pregnancy complications and its modulation. Front. Biosci. 13:985-994.
8. Koch, C. A., and J. L. Platt. 2007. T cell recognition and immunity in the fetus and mother. Cell. Immunol. 248:12-17.
9. Wilczynski, J. R., J. Kalinka, and M. Radwan. 2008. The role of T-regulatory cells in pregnancy and cancer. Front. Biosci. 13:2275-2289.
10. Bachy, V., D. J. Williams, and M. A. Ibrahim. 2008. Altered dendritic cell function in normal pregnancy. J. Reprod. Immunol. 78:11-21.
11. Kammerer, U., A. Kruse, G. Barrientos, P. C. Arck, and S. M. Blois. 2008. Role of dendritic cells in the regulation of maternal immune responses to the fetus during mammalian gestation. Immunol. Invest. 37:499-533.
12. Dörr, H. G., A. Heller, H. T. Versmold, W. G. Sippell, M. Herrmann, F. Bidlingmaier, and D. Knorr. 1989. Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J. Clin. Endocrinol. Metab. 68:863-868.
13. Tai, P., J. Wang, H. Jin, X. Song, J. Yan, Y. Kang, L. Zhao, X. An, X. Du, X. Chen, et al. 2008. Induction of regulatory T cells by physiological level estrogen. J. Cell. Physiol. 214:456-464.
14. Beagley, K. W., and C. M. Gockel. 2003. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol. Med. Microbiol. 38:13-22.
15. Hughes, G. C., and E. A. Clark. 2007. Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity 40:470-481.
16. Amano, Y., S. W. Lee, and A. C. Allison. 1993. Inhibition by glucocorticoids of the formation of interleukin-1 a, interleukin-1 β, and interleukin-6: mediation by decreased mRNA stability. Mol. Pharmacol. 43:176-182.
17. Elftman, M. D., C. C. Norbury, R. H. Bonneau, and M. E. Truckenmiller. 2007. Corticosterone impairs dendritic cell maturation and function. Immunology 122:279-290.
18. Mainali, E. S., and J. G. Tew. 2004. Dexamethasone selectively inhibits differentiation of cord blood stem cell derived-dendritic cell (DC) precursors into immature DCs. Cell. Immunol. 232:127-136.
19. Matyszak, M. K., S. Citterio, M. Rescigno, and P. Ricciardi-Castagnoli. 2000. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur. J. Immunol. 30:1233-1242.
20. Pan, J., D. Ju, Q. Wang, M. Zhang, D. Xia, L. Zhang, H. Yu, and X. Cao. 2001. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol. Lett. 76:153-161.
21. Piemonti, L., P. Monti, P. Allavena, M. Sironi, L. Soldini, B. E. Leone, C. Socci, and V. Di Carlo. 1999. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 162:6473-6481.
22. Tuckermann, J. P., A. Kleiman, K. G. McPherson, and H. M. Reichardt. 2005. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit. Rev. Clin. Lab. Sci. 42:71-104.
23. Huck, B., T. Steck, M. Habersack, J. Dietl, and U. Kämmerer. 2005. Pregnancy associated hormones modulate the cytokine production but not the phenotype of PBMC-derived human dendritic cells. Eur. J. Obstet. Gynecol. Reprod. Biol. 122:85-94.
24. Liang, J., L. Sun, Q. Wang, and Y. Hou. 2006. Progesterone regulates mouse dendritic cells differentiation and maturation. Int. Immunopharmacol. 6:830-838.
25. Yang, L., X. Li, J. Zhao, and Y. Hou. 2006. Progesterone is involved in the maturation of murine spleen CD11c-positive dendritic cells. Steroids 71:922-929. (Pubitemid 44286963)
26. Jones, L. A., J. P. Anthony, F. L. Henriquez, R. E. Lyons, M. B. Nickdel, K. C. Carter, J. Alexander, and C. W. Roberts. 2008. Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors. Immunology 125:59-69.
27. Lutz, M. B., N. Kukutsch, A. L. J. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92.
28. McBride, J., P. R. Ingram, F. L. Henriquez, and C. W. Roberts. 2005. Development of colorimetric microtiter plate assay for assessment of antimicrobials against Acanthamoeba. J. Clin. Microbiol. 43:629-634.
29. MacKenzie, C. J., E. Ritchie, A. Paul, and R. Plevin. 2007. IKKalpha and IKKbeta function in TNFalpha-stimulated adhesion molecule expression in human aortic smooth muscle cells. Cell. Signal. 19:75-80.
30. Thellin, O., B. Coumans, W. Zorzi, A. Igout, and E. Heinen. 2000. Tolerance to the foeto-placental 'graft': ten ways to support a child for nine months. Curr. Opin. Immunol. 12:731-737.
31. Juretic, K., N. Strbo, T. B. Crncic, G. Laskarin, and D. Rukavina. 2004. An insight into the dendritic cells at the maternal-fetal interface. Am. J. Reprod. Immunol. 52:350-355.
32. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738.
33. Doyle, S. E., R. O'Connell, S. A. Vaidya, E. K. Chow, K. Yee, and G. Cheng. 2003. Toll-like receptor 3 mediates a more potent antiviral response than Tolllike receptor 4. J. Immunol. 170:3565-3571.
34. Meylan, E., K. Burns, K. Hofmann, V. Blancheteau, F. Martinon, M. Kelliher, and J. Tschopp. 2004. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat. Immunol. 5:503-507.
35. Fitzgerald, K. A., D. C. Rowe, B. J. Barnes, D. R. Caffrey, A. Visintin, E. Latz, B. Monks, P. M. Pitha, and D. T. Golenbock. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198:1043-1055.
36. Le Goffic, R., V. Balloy, M. Lagranderie, L. Alexopoulou, N. Escriou, R. Flavell, M. Chignard, and M. Si-Tahar. 2006. Detrimental contribution of the Toll-like receptor (TLR) 3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2: e53.
37. Leclerc, P. M., N. Dubois-Colas, and M. Garenne. 2008. Hormonal contraception and HIV prevalence in four African countries. Contraception 77:371-376.
38. Cherpes, T. L., J. L. Busch, B. S. Sheridan, S. A. Harvey, and R. L. Hendricks. 2008. Medroxyprogesterone acetate inhibits CD8+ T cell viral-specific effector function and induces herpes simplex virus type 1 reactivation. J. Immunol. 181:969-975.
39. Hughes, G. C., S. Thomas, C. Li, M. K. Kaja, and E. A. Clark. 2008. Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells. J. Immunol. 180:2029-2033.
40. Komastu, T., D. D. Ireland, and C. S. Reiss. 1998. IL-12 and viral infections. Cytokine Growth Factor Rev. 9:277-285.
41. Marshall-Clarke, S., J. E. Downes, I. R. Haga, A. G. Bowie, P. Borrow, J. L. Pennock, R. K. Grencis, and P. Rothwell. 2007. Polyinosinic acid is a ligand for toll-like receptor 3. J. Biol. Chem. 282:24759-24766.
42. Lesmeister, M. J., R. L. Jorgenson, S. L. Young, and M. L. Misfeldt. 2005. 17Beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells. Reprod. Biol. Endocrinol. 3:74.
43. Par, G., J. Geli, N. Kozma, P. Varga, and J. Szekeres-Bartho. 2003. Progesterone regulates IL12 expression in pregnancy lymphocytes by inhibiting phospholipase A2. Am. J. Reprod. Immunol. 49:1-5.
44. Kontula, K., T. Paavonen, T. Luukkainen, and L. C. Andersson. 1983. Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem. Pharmacol. 32:1511-1518.
45. Stimson, W. H. 1986. Sex steroids, steroid receptors and immunity. In Hormones and Immunity. I. Berezi, and K. Kovacs, eds. MTP Press, Lancaster, United Kingdom. p. 93-119.
46. Sugino, N., C. M. Telleria, and G. Gibori. 1997. Progesterone inhibits 20alphahydroxysteroid dehydrogenase expression in the rat corpus luteum through the glucocorticoid receptor. Endocrinology 138:4497-4500.
47. Butts, C. L., S. A. Shukair, K. M. Duncan, E. Bowers, C. Horn, E. Belyavskaya, L. Tonelli, and E. M. Sternberg. 2007. Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int. Immunol. 19:287-296.
48. Jiang, H. R., E. Muckersie, M. Robertson, H. Xu, J. Liversidge, and J. V. Forrester. 2001. Secretion of interleukin-10 or interleukin-12 by LPS-activated dendritic cells is critically dependent on time of stimulus relative to initiation of purified DC culture. J. Leukoc. Biol. 72:978-985.
49. McKay, L. I., and J. A. Cidlowski. 1999. Molecular control of immune/inflammatory responses: interactions between nuclear factor-κ B and steroid receptor-signaling pathways. Endocr. Rev. 20:435-459.
50. Kalkhoven, E., S. Wissink, P. T. van der Saag, and B. van der Burg. 1996. Negative interaction between the RelA (p65) subunit of NF-kappaB and the progesterone receptor. J. Biol. Chem. 271:6217-6224.
51. Ogawa, S., J. Lozach, C. Benner, G. Pascual, R. K. Tangirala, S. Westin, A. Hoffmann, S. Subramaniam, M. David, M. G. Rosenfeld, and C. K. Glass. 2005. Molecular determinants of crosstalk between nuclear receptors and tolllike receptors. Cell 122:707-721.
52. Hiscott, J. 2007. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18:483-490.
53. Dahlberg, A., M. R. Auble, and T. M. Petro. 2006. Reduced expression of IL-12 p35 by SJL/J macrophages responding to Theiler's virus infection is associated with constitutive activation of IRF-3. Virology 353:422-432.
54. Reily, M. M., C. Pantoja, X. Hu, Y. Chinenov, and I. Rogatsky. 2006. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J. 25:108-117.
55. Li, X., and B. W. O'Malley. 2003. Unfolding the action of progesterone receptors. J. Biol. Chem. 278:39261-39264.
56. Schmidt, B. M. W., D. Gerdes, M. Feuring, E. Falkenstein, M. Christ, and M. Wehling. 2000. Rapid, nongenomic steroid actions: A new age? Front. Neuroendocrinol. 21:57-94.
57. Ehring, G. R., H. H. Kerschbaum, C. Eder, A. L. Neben, C. M. Fanger, R. M. Khoury, P. A. Negulescu, and M. D. Cahalan. 1998. A nongenomic mechanism for progesterone-mediated immunosuppression: inhibition of K+ channels, Ca2+ signaling, and gene expression in T lymphocytes. J. Exp. Med. 188:1593-1602.